BATCH-1652 · filed

Regulation & Compliance

US FDA requires tamper-resistant packaging for cosmetics

FDA now requires tamper-resistant packaging for cosmetics, adding repackaging and documentation duties to brand compliance programs already stretched by MoCRA.

By Marcus Bennett · · 2 min read · 432 words

Composition

  1. US FDA has issued a requirement for tamper-resistant packaging on cosmetic products.
  2. The mandate adds to existing MoCRA-era obligations such as facility registration and product listing.
  3. Brands must confirm compliance of current components with suppliers and plan for redesign cycles where packs fall short.

The US FDA has issued a requirement for tamper-resistant packaging on cosmetic products, a move that directly alters specifications for packaging procurement and compliance workflows across the beauty and personal care industry.

For formulators and brand owners, the requirement means every primary pack in a US cosmetic portfolio must now be assessed against tamper-resistance criteria before market placement. Packaging suppliers will need to document the tamper-evident or tamper-resistant features of closures, seals, sleeves and cartons — and brands should expect to request and archive that documentation as part of their regulatory files.

The obligation lands on top of an already crowded US compliance calendar. Since the Modernization of Cosmetics Regulation Act (MoCRA) took effect, companies have already absorbed facility registration, product listing and safety substantiation duties. The packaging mandate adds another layer: artwork, filling-line and component-qualification changes where existing packs do not meet the new standard.

The practical impact will vary by category. Products sold in sealed retail cartons may need little more than documented evidence of tamper-evident design. Open-sale formats — compacts, jars, lipsticks displayed without secondary packaging — are the harder cases, likely requiring engineering changes to closures or the addition of seals and overwraps. Each affected SKU means a packaging redesign cycle, component requalification, stability and compatibility checks, and updated labeling if any consumer-facing tamper indicator is added.

For procurement teams, the timing matters. Sourcing tamper-resistant closures at scale across a full portfolio will compete for tooling and component capacity, and lead times for custom packaging typically run months. Brands planning launches or restocks in the coming quarters should confirm with suppliers, in writing, whether current components satisfy the FDA requirement — and where they do not, how quickly alternatives can be validated.

Contract manufacturers and private-label players carry a share of the burden too. Their customers will demand evidence of compliant packaging, and filling lines may need adjustment for new closure types or seal application steps. Expect packaging documentation requests to become standard in manufacturing agreements.

The requirement also touches professional channels. Salons, spas and treatment providers that retail products must ensure the items on their shelves meet the federal standard, which may mean reviewing supplier attestations for retail-line products kept on backbars and at checkout.

What to watch next: the effective date and any FDA guidance defining which packaging formats qualify as tamper-resistant. Those two details will determine whether this is a labeling-and-documentation exercise for most brands or a full portfolio repackaging program — and companies should build their project timelines around whichever date the agency sets.

via Google News - Cosmetics Regulation (Source)

Filed under

  • fda
  • mocra
  • packaging
  • cosmetics-regulation
  • tamper-resistant-packaging

More from Marcus Bennett

Marcus Bennett

Show full bio

Correspondent covering consumer brands and retail at INCI File.

106 articles

Cross-references · Related articles

« Previous articleNext article »

End of monograph · 2 min read